Multiple sclerosis Flashcards

1
Q

What is MS?

A

neurodegenerative autoimmune condition that attacks the CNS (myelin sheaths on the axons), combination of genetic and environmental factors. Characterised by multiple episodes of neurological symptoms then remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How many people roughly have MS?

A

60,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the symptoms of MS

A

Weakness
numbness
loss of senses
loss of balance, slips and trips

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are Uhtoffs and Lhermitts phenomena?

A

Uhtoffs - symptoms worse on increased body temp

Lhermittes - electrical sensation running down the spine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What type of disease is MS?

A

Relapsing and remitting (initially get relapse as CNS repairs itself but most go on to be chronic progressive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 3 pathological hallmarks of MS

A
  1. inflammation of brain and spinal cord leading to acute loss of function and immune cells which attack cells involved in myelination (plaques)
  2. Demyelination loss of myelin sheaths so nerves cannot transmit APs
  3. Neurodegeneration due to the accumulation of demyelination and inflammation which leads to axonal loss and neuronal death.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the causes of MS

A

Genetics e.g. family is a major part

Environment e.g. infection, epstein barr virus, low sunlight/vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is treatment of an acute relapse of MS?

A

Oral methylprednisolone 500mg/day for 3-5 days to reduce immune response and inflammation (high dose) (or IV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some treatments in MS

A
Natalizumab 
Fingolimod
dimethyl fumarate (tecfidera)
Alemtuzumab 
Teriflunomide CCS immunomodulator
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How common is bladder /bowel problems in MS patients and how can this be treated?

A

70-80% of patients

Treated via sativex, alfuzocin, trospium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what % of MS patients have pain?

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What can be used to treat spascity? 1st line and 2nd line

A

Baclofen
Gabapentin

2nd line: sativex (cannabinoid) tizanidine, diazepam, Intrathecal baclofen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a drug that MS patients commonly use to self medicate with? how does this help? What are the legal aspects of this use?

A

Cannabis - tremor, spasticity, pain, bladder

It is illegal in the UK under the misuse of drugs act 1971/2001 and not recommended by NICE.
CBD oil can be bought OTC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What mab is now available on the NHS for MS? What is its MoA?

A

Alemtuzumab - it is an anti-CD52 antibody that reduces inflammatory response in early MS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is the prevalence much higher than the incidence?

A

Because people can live with MS for many years. Not many new cases per year but many people living with it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the positive phenomena caused by (uhtoffs and Lhermittes)

A

Hyperexcitability due to demyelination

17
Q

What is fingolimod (Gileyna) and what is the criteria that a patient should meet to receive it?

A

Sphingosine analogue.
Criteria: must have an unchanged or increased rate of ongoing severe relapses compared to previous year despite treatment with beta interferon, AND the manufacturer provides it with discount as part of the patient access scheme

18
Q

If a patient has. cognitive. symptoms - would. you use medication?

A

Yes if there is a decline in function as majority of MS patients have some sort of cognitive decline e.g. Donepazil, but they haven’t gone through Clinical trials in MS patients so it is not recommended by NICE- not recommended for this indication - off label use

19
Q

What are future treatment considerations for MS?

A

Stem cell therapy but expensive and unlikely to be on NHS